#Foods that increase immunity against covid 19

[covid-safer-hotties]

Also preserved on our archive

By Jessica Rendall

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

We're on the cusp of the fall season, which means respiratory viruses like flu, RSV and COVID are expected to keep spreading as weather cools and more people gather indoors.

Luckily, we've got vaccines in stock to help prevent respiratory viruses from turning into severe illnesses. In addition to flu vaccines for the general public and RSV vaccines for older adults and pregnant people, new COVID vaccines from Pfizer-BioNTech, Moderna and Novavax are available this season to reduce the risk of hospitalization.

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way. All three have been authorized by the US Food and Drug Administration. While Moderna and Pfizer have been widely used over the last few years, the Novavax vaccine is building up a bit of a following.

Novavax, a protein-based vaccine, is an option for those who don't want or can't take an mRNA vaccine. Novavax may also be appealing to those wanting to experiment with the "mix-and-match" approach to COVID boosters as a way to potentially strengthen the immune response.

"Even though mRNA vaccines dominate the market for COVID vaccines, it remains important to have multiple different types of technologies against various pathogens because each may have specific use cases," Dr. Amesh Adalja, an infectious disease expert and senior scholar with Johns Hopkins Center for Health Security, said in an email.

Here's everything we know about Novavax this year.

How is Novavax different from Pfizer and Moderna? Novavax is a protein-based vaccine, which people have associated with a "traditional" approach to vaccination. This is compared with mRNA technology, which does not use dead or weakened virus as an ingredient in the vaccine but instead uses genetic code to instruct the recipient's immune system to respond.

However, Adalja said that calling Novavax traditional may be a "misnomer" because it brings its own innovation to the table. Novavax uses an insect virus that has been genetically engineered to express spike proteins, Adalja explained, which are then incorporated into the vaccine.

"The vaccine itself is coupled with an immune system booster, called an adjuvant, which increases its immunity," he said, referencing a component existing vaccines have also incorporated.

This year, there are also slight differences between Novavax and Pfizer and Moderna's updated vaccines. Both mRNA vaccines have been tweaked to target the KP.2 strain of COVID-19, which is a slightly more recent version of the virus than what Novavax targets, which is KP.2's "parent" JN.1. While the FDA ultimately decided KP.2 was preferred in vaccines, all of them are expected to help protect against severe disease and death.

Who should get Novavax? Does Novavax have different side effects? Novavax was authorized by the FDA for use in adults and children 12 and older, so younger kids can't get this vaccine. But for most adults, which COVID vaccine you should choose depends on your preference and what your neighborhood pharmacy has in stock.

People may opt for Novavax for different reasons, though. For people who do not want to take an mRNA vaccine, having a protein-based vaccine like Novavax available means they can still be vaccinated for the fall and winter season.

Other people may be interested in Novavax for its use in the "mix-and-match" approach to boosting, which in the past has been associated with a strong immune response.

There is some early research that suggests Novavax may have fewer short-term side effects, such as muscle fatigue and nausea, but "we can't say this for sure," Joshua Murdock, a pharmacist and pharmacy editor of GoodRx, said in an email.

"This isn't proven, and side effects do vary by person," Murdock said. He added the CDC doesn't recommend one vaccine over the other, even in people who are immunocompromised.

In general, mRNA vaccines have been found to be fairly "reactogenic" compared to other vaccines, Adalja said, noting that it also depends on the individual. But if someone had a bad experience with the mRNA vaccine, Adalja said, they "may fare better with the Novavax vaccine."

Some flu-like side effects can be expected post-vaccine, no matter which one you choose. This includes symptoms like headache, tiredness, a sore arm and even chills. Not experiencing symptoms doesn't mean your immune system isn't kicking in, but experiencing some side effects may signal that your immune system is responding to the jolt, so to speak.

In rare cases, myocarditis or heart inflammation problems have been associated with COVID vaccination, particularly in younger men and adolescents within the two weeks following vaccination. Research so far shows that Novavax, like mRNA vaccines, may also carry this rare side effect though.

Following high levels of COVID this summer in the US, more information will be needed to see how all vaccines and their freshly targeted formulas fare against the virus that's expected to continue to spread this fall and winter.

"There's no strong evidence that one vaccine is preferable to another in specific individuals, but that will be an important avenue to study for more precision-guided vaccine recommendations," Adalja said.

How to find a Novavax vaccine Novavax announced on Sept. 13 that doses of its vaccine will be available at the following pharmacies:

CVS Rite Aid Walgreens Costco Publix Sam's Club Kroger Meijer Other independent pharmacies or grocers

Novavax also has a vaccine finder on its website. To use it, type in your ZIP code in the small search box, and pharmacies nearby with the vaccine in stock will be displayed.

[follow-up-news]

The U.S. is experiencing more than four times as many whooping cough cases compared with last year — a spike that some experts attribute to post-pandemic vaccine fatigue. “With the increase in vaccine hesitancy that has been going on since the Covid-19 pandemic, we’re seeing outbreaks occurring in kids who are not vaccinated,” said Dr. Tina Tan, president-elect of the Infectious Diseases Society of America. Babies are given the DTaP vaccine, which helps protect against three diseases: pertussis, diphtheria and tetanus. The vaccine works well against diphtheria and tetanus, but is less effective over time for pertussis. Advisors to the Food and Drug Administration met Friday to discuss the need for more robust and longer-lasting versions of the whooping cough vaccine. Until next generation vaccines are developed, boosters are recommended about every 10 years, starting in the tween years, as kids start middle school. It’s the tweens and teens whose immunity against whooping cough has waned that are driving outbreaks in many states, experts say.

[didanawisgi]

"Anyone familiar with biology will recognize that biological systems and phenomena are often very complex. The more one studies biology in detail, the more one becomes aware of its intrinsic complexity. Molecular biologists will certainly agree with this. The level of sophistication increases even more as biological systems become more vulnerable, especially when interactions with other biological systems create dynamics that are vital for their maintenance. This is why the level of biological complexity within entire ecosystems culminates at a point that is difficult for humans to fully comprehend.

But what is the biological significance of this complexity? The complexity of biological phenomena often resembles a real spiderweb, where, much like a busy traffic intersection, many paths cross and change direction. By alternating steps in one direction with steps in another, often even opposite direction, it becomes possible to continuously adjust, modulate, and refine biological processes and reactions. This not only leads to a high degree of sophistication, and therefore vulnerability, in vital biological phenomena but also to a high degree of versatility and diversity. It is precisely this variation that is crucial for ensuring that complex, and hence more fragile, biological systems can thrive, even in the face of environmental threats. This is especially true when these threats come from biological agents that have evolved to sustain themselves with a much lower degree of biological complexity and vulnerability. It is precisely the spectrum of variations generated by the complexity of biological processes themselves and the myriads of mutual interactions with other systems that creates a wide range of possibilities for these vulnerable systems to adapt purposefully to threatening environmental factors. This adaptation occurs through the natural selection of the random’ variant(s)’ whose phenotypic complexity confers a competitive fitness advantage in hostile circumstances.

If the responsiveness of autonomously living biological organisms consisted only of a simple black-and-white reaction, then the confrontation with an unfavorable environmental factor would either result in a large-scale extinction of the species or in its widespread survival, ultimately leading to other factors that could also threaten the species' survival (e.g., depletion of food resources or other detrimental consequences of overpopulation). However, when the adaptability of an entire ecosystem—such as an animal population interacting with a pathogenic germ—is undermined by an unnatural, ill-adapted large-scale intervention, the population's capacity to effectively control the pathogen is at risk of gradually declining. It is not difficult to understand that this is particularly true when the 'hostile' environmental threat comes from a viable biological agent that, due to its primitive reproduction strategy, is much less vulnerable because it only needs to survive and reproduce within the safe environment of a host cell, such as a virus. In this way, the roles are reversed, and the more evolved and vulnerable organism gradually loses its ability to adapt, giving the more primitive adversary a strategic advantage.

For those who have followed my insights and predictions regarding the endpoint of the ongoing immune escape pandemic, this precisely explains how mass vaccination against SARS-CoV-2 during the pandemic has actually benefited the virus's adaptation, rather than that of the Covid 19 (C19)-vaccinated population. The systematic breakthrough infections in C19-vaccinated individuals have led to a collective reduction in the immune system’s adaptability (i.e., adaptive immunity) of highly C-19 vaccinated populations, thereby improving the survival chances of the less vulnerable virus. The adaptive capacity of highly C-19 vaccinated populations has eventually been limited to protection against virulence through polyreactive non-neutralizing antibodies (PNNAbs), a protection that we know does not evolve further and cannot prevent the virus from spreading (and thus adapting). Because the evolutionary dynamics of the virus, fueled by nonpharmaceutical infection-prevention measures and mass vaccination, have caused the antigenic stimulus that maintained the concentration of these antibodies to disappear, it seems more than plausible that this human-induced viral dynamics will ultimately pull the emergency brake to prevent the extinction of highly C-19 vaccinated populations. Indeed, if the collective immunological adaptability is restricted to the extent that it prevents the development of herd immunity, then only a higher degree of adaptability of the virus can offer a solution. The evidence of the virus's increasing adaptability has become clearly visible for quite some time, especially since the emergence of Omicron. At the current stage of this immune escape pandemic, the virus's adaptability is only further stimulated by the increasingly reduced capacity of highly C-19 vaccinated populations to control viral spread and replication.

There is no doubt that under the significant but 'misplaced' immune pressure exerted by highly C-19 vaccinated populations, the virus’s unchecked adaptability can only escalate. This escalation could ultimately give the unvaccinated part of these populations the opportunity to establish herd immunity through epigenetic reprogramming (‘adaptation’) of their innate immune cells, thereby breaking the cycle of ongoing immune escape by the virus.

It is also logical that when the robust adaptability of vulnerable biological entities is disrupted, it may take some time before their stability is collectively undermined and the system collapses under hostile pressure. Nevertheless, it’s clear that when small cracks in a dam’s wall begin to expand into larger fissures, the system’s stability deteriorates very rapidly, and thus the metastable system can suddenly collapse, much like a thunderbolt striking out of a clear sky. Such entities will therefore likely be caught off guard…

Together with those who criticize the timeline I predicted for the termination of the C-19 immune escape pandemic, I am amazed by the remarkable resilience of the complex biological system involved. This can only mean that the ability of our mammalian immune system to collectively adapt to far less biologically complex pathogens is truly spectacular and shows a resilience of unprecedented magnitude. Such remarkable resilience can only be destroyed by large-scale, unnatural and thoughtless immune interventions, but not in a way that nature has not provided a contingency plan to ensure the survival of our species..."

[xtruss]

We're Having A COVID Summer Surge. Should You Get The Updated Vaccines Now?

The FDA Just Approved an Updated Vaccines, and Officials Say Paxlovid is Still Effective in Preventing Severe Cases.

— By Sanjay Mishra | August 22, 2024

A Colorized Ccanning Electron Micrograph of a Cell (Blue) Infected with the Omicron Strain of the SARS-CoV-2 virus (Yellow). Micrograph By National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes Of Health/Science Photo Library

The summer of 2024—the fifth since the COVID-19 pandemic began—is projected to be the biggest summer wave of COVID infections to date.

Since early May, COVID infections have steadily increased in the United States, Europe, Singapore, New Zealand, and Australia. The U.S. Centers for Disease Control and Prevention estimates that COVID-19 infections are currently increasing in 25 states based on data from emergency department visits. However, hospitalizations and deaths from COVID remain at their lowest levels.

Now, the U.S. Food and Drug Administration has approved updated vaccines to protect against current variants of the virus.

This recent surge has been driven mainly by a new group of closely related Covid subvariants, known collectively as "FLiRT."

As the summer winds down, students across the U.S. will return to school. Traditionally, this also coincides with the season of respiratory viruses, such as flu, RSV, and increasingly COVID.

"Not sure what will happen this fall and winter," says Kei Sato, a virologist at the University of Tokyo. While the FLiRT variants are likely to keep evolving after summer, entirely new subvariants cannot be ruled out. "An Omicron-like event” seems to have occurred every year in the fall since 2021, says Sato.

Here's what you need to know about the new variants and the new vaccines.

What Are FLiRT Variants?

The "FLiRT" variant family includes the majority of currently circulating variants, identified with the letters KP, JN, and the variant LB.1.

The unofficial name "FLiRT" is an acronym for a set of mutations on the spike protein of SARS-CoV-2, the virus that causes COVID-19. The virus uses spike protein to bind with ACE2 receptors in our nose and lung cells to cause infection.

All proteins are made up of amino acids that string together like beads. Mutations can change one amino acid to another, thereby altering the behavior of the protein and making the virus more or less infectious, or able to dodge immunity.

The FLiRT subvariant family members are descended from the JN.1 variant that was dominant in the U.S. in early 2024. JN.1 itself was highly unusual because it acquired 41 mutations that differentiated it from Omicron XBB.1.5, which is the variant upon which the current bivalent COVID booster is based.

Should You Get The New Vaccines?

The two updated mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target a FLiRT variant called KP.2. Anyone over the age of 12 can get the new shots, as long as they haven't received a booster in the last two months.

“Vaccination continues to be the cornerstone of COVID-19 prevention,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a statement.

Another vaccine targeting the variant JN.1 and manufactured by Novovax is also under review and could be approved soon.

Previous research also showed that older vaccines based on XBB.1.5, an earlier subvariant of Omicron, were still effective in preventing severe COVID-19. While this vaccine produces antibodies that still target the FLiRT variants, the efficiency is notably reduced. A recent infection from the JN.1 variant also seems to provide strong protection against all the FLiRT variants.

That said, the CDC recommends that everyone six months and older get a COVID vaccine. Those at high risk for serious COVID-19 should get vaccinated with the most recent versions available.

How Alarming Are FLiRT Variants?

Coronaviruses, such as SARS-CoV-2, frequently mutate to avoid recognition by antibodies. The two FLiRT mutations remove the sites on the virus where antibodies bind the SARS-CoV-2 virus.

Additional mutations on the FLiRT variants can either help the virus bind more efficiently to ACE2 receptors making it more infectious, help it evade previous immunity, or both, says Adrian Esterman, an epidemiologist at the University of South Australia, Allied Health & Human Performance in Adelaide, Australia

Early studies show that all existing FLiRT subvariants are very good at dodging previous immunity acquired through multiple COVID vaccinations—including the most recent COVID bivalent booster—or a breakthrough infection from a previous strain of Omicron.

But the good news is that by escaping the antibodies, the FLiRT variants have also seem to lost some ability to infect their target because the virus needed the original antibody-binding sites to bind the ACE2 receptor and enter cells.

"These variants are not yet particularly concerning, even with the new mutations that affect certain aspects of the virus's biology," says Shan-Lu Liu, a virologist at the Ohio State University.

It is common for viruses to acquire mutations that help them dodge immunity, which can affect their ability to infect cells, says Liu. "The viruses can quickly evolve new mutations to restore their infectivity."

But in the meantime, Sato thinks that waning immunity from previous vaccinations and infections, coupled with the FLiRT variant's ability to dodge remaining immunity, are probably the main reason for the recent surge in infections.

Liu also agrees that the currently rising numbers of COVID infections are mostly due to low booster uptake and increased summer travel.

Are COVID Medicines Still Effective?

Emergency department visits, hospitalizations, and deaths have all spiked during this summer but are still much lower compared to earlier waves of the pandemic.

There is no indication that these new FLiRT variants are more dangerous than other Omicron strains.

A study shows that Paxlovid is still effective against FLiRT variants. Other antiviral drugs such as molnupiravir and remdesivir are also expected to work since their mechanism of action is not affected by mutations in the spike protein.

[chemanalystdata]

Vitamin C Prices Trend | Pricing | News | Database | Chart

 Vitamin C, also known as ascorbic acid, is a widely consumed antioxidant with numerous health benefits, including immune support, skin health, and improved overall wellness. Its importance in pharmaceuticals, food and beverages, and dietary supplements makes it a critical ingredient across industries. Consequently, the global price of Vitamin C fluctuates based on several factors, including raw material availability, production capacity, regional demand, and economic conditions. Understanding these dynamics provides insight into the current trends and future expectations for Vitamin C pricing.

The production of Vitamin C is heavily dependent on specific raw materials, such as corn or sugar, which serve as the primary feedstock in its manufacturing process. Any fluctuation in the availability or cost of these raw materials directly impacts the production costs, subsequently influencing market prices. For instance, disruptions in corn supply due to unfavorable weather conditions or geopolitical tensions can cause a ripple effect, increasing production expenses for Vitamin C manufacturers. Additionally, energy costs are another crucial factor since production processes often require significant energy input. Rising energy prices typically push up production costs, leading to higher market prices for Vitamin C.

Get Real Time Prices for Vitamin C: https://www.chemanalyst.com/Pricing-data/vitamin-c-1258

The geographical distribution of Vitamin C production also plays a significant role in determining its price. China is the leading producer of Vitamin C, accounting for a substantial portion of the global supply. Changes in Chinese manufacturing policies, environmental regulations, or labor costs can have an immediate impact on the market. For example, stricter environmental regulations in China in recent years have led to temporary shutdowns of manufacturing facilities, reducing global supply and driving up prices. Conversely, when production stabilizes, prices tend to level out, reflecting the balance between supply and demand.

Demand for Vitamin C has seen significant growth in recent years, driven by increased health awareness among consumers. The COVID-19 pandemic, in particular, highlighted the importance of immune health, leading to a surge in demand for Vitamin C supplements. This sudden spike in demand caused temporary price hikes as manufacturers scrambled to meet the market's needs. While the urgency associated with pandemic-related purchases has subsided, the general trend of health-conscious consumers incorporating Vitamin C into their daily routines continues to sustain demand, particularly in regions like North America, Europe, and Asia-Pacific.

Seasonal variations also contribute to the fluctuation in Vitamin C prices. Demand typically increases during the colder months when consumers seek to bolster their immune systems against colds and flu. This seasonal uptick often results in higher prices, especially if supply chains face constraints during peak demand periods. Moreover, price differences can emerge across various forms of Vitamin C, such as powders, tablets, and liquid formulations, depending on consumer preferences and manufacturing complexities.

The competitive landscape of the Vitamin C market further influences pricing dynamics. Leading manufacturers often adjust their prices to remain competitive while maintaining profitability. Innovations in production techniques or the introduction of more cost-effective methods can sometimes lead to price reductions. However, market consolidation, where a few players dominate the supply, can lead to price stabilization or even inflation, particularly if smaller producers struggle to compete. This interplay of competition and market power continues to shape the pricing environment.

Trade policies and tariffs also play a pivotal role in determining the cost of Vitamin C in international markets. For instance, tariffs imposed on Chinese imports can lead to higher prices in regions reliant on Chinese supplies. Similarly, transportation and logistics costs influence the final price, especially in light of recent disruptions in global supply chains. The ongoing challenges in shipping and freight have added a layer of complexity to the Vitamin C market, with increased logistics costs often being passed on to consumers.

Technological advancements and sustainability trends are also impacting Vitamin C pricing. Manufacturers are increasingly investing in sustainable production methods to meet consumer demand for environmentally friendly products. While these efforts are commendable, they often come with higher production costs, potentially leading to price increases. On the other hand, the adoption of advanced technologies that improve production efficiency could help mitigate cost pressures, leading to more competitive pricing over time.

The future of Vitamin C pricing is likely to be shaped by evolving consumer preferences, regulatory changes, and advancements in production processes. As the demand for clean-label and plant-based ingredients grows, manufacturers may face additional challenges in sourcing raw materials that align with these trends. Additionally, regulatory scrutiny over the quality and safety of dietary supplements could influence production practices and costs, thereby affecting market prices. Despite these challenges, the overall outlook for Vitamin C pricing remains positive, with steady demand expected to support the market's growth in the coming years.

In conclusion, Vitamin C prices are influenced by a complex interplay of factors, including raw material costs, production capacities, regional demand, and global economic conditions. The dominance of China as a leading producer, coupled with seasonal variations and evolving consumer trends, adds layers of complexity to the pricing landscape. While challenges such as supply chain disruptions and regulatory pressures persist, advancements in technology and sustainability efforts hold promise for stabilizing costs. Understanding these dynamics is essential for businesses and consumers alike, as they navigate the ever-evolving market for this essential nutrient.

Welcome to ChemAnalyst App: https://www.chemanalyst.com/ChemAnalyst/ChemAnalystApp

Contact Us:

ChemAnalyst

GmbH - S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com

[tamanna31]

Commercial Refrigeration Equipment Market Size, Share, Growth, Analysis Forecast to 2030

Commercial Refrigeration Equipment Market Size & Trends 

The global commercial refrigeration equipment market size was valued at USD 40.82 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. The rapid expansion of the hospitality and tourism sector and the growing preference among end-consumers for takeaway meals are expected to drive market growth over the forecast period. In addition, increasing regulatory implications resulting in the adoption of lower global warming potential (GWP) commercial refrigerants coupled with ongoing technological breakthroughs will also provide growth prospects for the market. 

A considerable rise in the international food trade has also boosted the demand for commercial refrigeration systems for frozen foods, processed foods, and seafood required for to storage and transportation. The continual innovations and rapid improvements in technologies, including liquid-vapor compression and ammonia absorption systems, are driving the product demand further. Various leading manufacturers are focusing on R&D activities to enhance the design and temperature control of their products to gain a competitive edge in the industry. The increasing need to control and monitor the environment of a commercial kitchen is expected to provide ample growth opportunities for the refrigeration industry over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Commercial Refrigeration Equipment Market 

Products equipped with automated or smart refrigeration controls are gaining massive traction in the market. As per the Federal Energy Management Program, commercial refrigerators with ENERGY STAR certification consume 1.89 kWh energy per day on an average, while refrigerators with lesser efficiency consume energy of around 4.44 kWh per day. The increasing demand for energy-efficient commercial refrigeration units driven by the rising awareness about their environment-friendly and cost-effective nature is encouraging the market players to develop innovative designs. 

Climate concerns related to high GWP refrigerants, such as global warming and ozone depletion, are urging manufacturers to produce alternatives. The rising demand for technologies that can address hazardous gas emissions has urged market participants to equip their products with advanced magnetic refrigeration systems. These systems also improve the energy efficiency of refrigeration equipment, thereby minimizing operational costs. As per the U.S. Department of Energy statistics, these systems are highly energy-efficient and can help in energy saving of up to 30%. 

The worldwide outbreak of the COVID-19 crisis led to the establishment of stringent containment measures, resulting in a temporary halt in the manufacturing and shipment of commercial refrigeration equipment. However, the pandemic created a strong demand for vaccine production and storage, which triggered the demand for cold storage solutions to support the mass immunization program against the coronavirus. The accelerating usage of vaccine storage units is likely to propel the demand for transportation refrigeration equipment in the subsequent years. 

Browse through Grand View Research's Next Generation Technologies Industry Research Reports.

The global unmanned traffic management market size was estimated at USD 164.1 million in 2023 and is projected to grow at a CAGR of 34.0% from 2024 to 2030. The growing adoption of drones in various sectors, such as agriculture, logistics, and emergency services, has created a need for effective unmanned traffic management (UTM) systems, thereby driving market growth. The demand for UTM solutions to manage airspace safely and efficiently is growing as drones are increasingly used for commercial purposes.

The global border security market size was estimated at USD 26.76 billion in 2023 and is expected to grow at a CAGR of 6.8% from 2024 to 2030. The market growth is driven by the increasing geopolitical tensions, cross-border crimes, and the need for advanced surveillance systems. Governments worldwide are investing heavily in modernizing their border security infrastructure to enhance national security. The market encompasses a wide range of technologies, including unmanned aerial vehicles (UAVs), biometrics, radar systems, and advanced detection and tracking systems.  

Commercial Refrigeration Equipment Market Segmentation 

Grand View Research has segmented the global commercial refrigeration equipment market report based on the product, application, system type, refrigerant, capacity, distribution channel, and region 

Commercial Refrigeration Equipment Product Outlook (Revenue, USD Million, 2018 - 2030)

Transportation Refrigeration Equipment

Trailers

Trucks

Shipping Containers

Refrigerators & Freezers

Walk-in-Refrigerators

Reach-in Refrigerators

Chest

Beverage Refrigeration

Display Showcases

Ice Cream Cabinets

Bakery/Deli Display

Others

Ice Merchandisers & Ice Vending Equipment

Other Equipment 

Commercial Refrigeration Equipment System Type Outlook (Revenue, USD Million, 2018 - 2030)

Self-contained

Remotely Operated 

Commercial Refrigeration Equipment Capacity Outlook (Revenue, USD Million, 2018 - 2030)

Less than 50 cu. Ft

50 to 100 cu. Ft

More than 100 cu. Ft 

Commercial Refrigeration Equipment Application Outlook (Revenue, USD Million, 2018 - 2030)

Food Service

Food & Beverage Retail

Hypermarkets

Supermarkets

Convenience Store

Specialty Food Store

Others

Hotels and Hospitality

Pharmaceuticals

Healthcare

Biotechnology

Chemicals

Others 

Commercial Refrigeration Equipment Refrigerant Outlook (Revenue, USD Million, 2018 - 2030)

Synthetic Refrigerants (HFCs, HCFCs)

Natural Refrigerants

Carbon Dioxide (CO2)

Ammonia (NH3)

Others 

Commercial Refrigeration Equipment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

OEMs (Original Equipment Manufacturers)

Distributors and Wholesalers

Retailers 

Commercial Refrigeration Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

Germany

U.K.

France

Italy

Spain

Asia Pacific

Japan

China

India

South Korea

Australia

Latin America

Brazil

Mexico

Middle East and Africa (MEA)

Saudi Arabia

South Africa

Order a free sample PDF of the Commercial Refrigeration Equipment Market Intelligence Study, published by Grand View Research. 

Key Companies profiled:

AHT Cooling Systems GmbH

Ali Group S.r.l. a Socio Unico

Carrier

Daikin Industries Ltd.

Dover Corporation

Electrolux AB

Hussmann Corporation

Illinois Tool Works Inc.

Johnson Control

Lennox International Inc.

Panasonic Corporation

Whirlpool Corporation 

Recent Developments

In January 2024, Hussmann Corporation, a retail refrigeration systems company, launched Evolve Technologies, a new offering focused on the development of technologies that facilitate the use of environmentally friendly refrigerants. 

In January 2022, Carrier Commercial Refrigeration installed its PowerCO2OL refrigeration system at a COVID-19 vaccine storage warehouse in Spain. This system uses carbon dioxide, a natural refrigerant, and serves as a sustainable and low global warming potential refrigerant to help preserve critical vaccines in Spain. 

[visionarycios]

The Connection Between Vitamin D Deficiency and COVID-19

Vitamin D deficiency is a topic of significant interest, especially after the COVID-19 pandemic. This key nutrient is often called the “sunshine vitamin” as sunlight is the main source your skin absorbs from the sun’s ultraviolet rays and turns them into vitamin D. Its intake is crucial to maintaining health. Vitamin D is very important because it keeps our bones strong. But many people lack enough. People with darker skin, poor diets, and the elderly are more prone to being affected. In this article, we’ll get to know the importance of Vitamin D. 

Understanding Vitamin D

Vitamin D is a fat-soluble vitamin. It’s vital for keeping bones healthy and for supporting the immune system. It helps the body absorb calcium and phosphorus. There are two main forms of Vitamin D. They are Vitamin D2 and Vitamin D3. Vitamin D2 comes from plants and supplements. Vitamin D3 is produced in the skin in response to sunlight exposure and is also found in animal-based foods. To avoid Vitamin D deficiency and keep healthy bones, we must include food with Vitamin D in our diet.

Causes and Symptoms of Vitamin D Deficiency

Vitamin D deficiency occurs when the levels of this vitamin in the body are too low. Common causes include:

Limited Sun Exposure: People who live in northern latitudes, spend a lot of time indoors, or wear sunscreen may not get enough sunlight to produce adequate Vitamin D.

Dietary Insufficiency: Diets low in Vitamin D-rich foods such as fatty fish, eggs, and fortified dairy products can contribute to deficiency.

Age: Older adults have a reduced ability to synthesize Vitamin D from sunlight.

Skin Pigmentation: Individuals with darker skin have higher levels of melanin, which can reduce the skin’s ability to produce Vitamin D from sunlight.

Health Conditions: Certain medical conditions, such as Crohn’s disease and celiac disease, can affect the body’s ability to absorb Vitamin D.

Symptoms of Vitamin D deficiency can be subtle but may include:

Fatigue and tiredness

Bone pain and muscle weakness

Mood changes, including depression

Impaired wound healing

Hair loss

The Immune System and Vitamin D

Vitamin D is known to play a critical role in the immune system. It enhances the pathogen-fighting effects of monocytes and macrophages — white blood cells that are important parts of your immune defense — and decreases inflammation. This immunomodulatory effect is crucial in protecting the body against infections

Vitamin D and Respiratory Infections

Before diving into the specifics of COVID-19, it’s essential to understand the general relationship between Vitamin D and respiratory infections. Several studies have indicated that Vitamin D supplementation can reduce the risk of acute respiratory infections. This protective effect is particularly pronounced in individuals having vitamin deficiency.

Vitamin D Deficiency and COVID-19: The Evidence

Since the onset of the COVID-19 pandemic, researchers have been investigating the potential connection between Vitamin D deficiency and COVID-19 outcomes. Although the evidence is still evolving, several studies have highlighted intriguing correlations:

1. Increased Susceptibility

Some studies suggest that individuals with Vitamin D deficiency may be more susceptible to contracting SARS-CoV-2, the virus responsible for COVID-19.

2. Severity of Disease

Research indicates that Vitamin D deficiency might be linked to more severe outcomes in COVID-19 patients. This includes higher rates of hospitalization, complications, and mortality.

3. Inflammatory Response

Vitamin D’s role in modulating the immune system could be critical in controlling the inflammatory response in severe COVID-19 cases, such as cytokine storms.

4. Respiratory Health

Given Vitamin D’s importance in respiratory health, deficiency could exacerbate respiratory symptoms and complications associated with COVID-19.

Studies Supporting the Connection

Several studies have supported the potential link between Vitamin D deficiency and COVID-19. For example:

A study published in the Journal of Clinical Endocrinology & Metabolism found that over 80% of COVID-19 patients in a hospital in Spain had Vitamin D deficiency.

Research from the University of Chicago suggested that patients with untreated Vitamin D deficiency were more likely to test positive for COVID-19.

A meta-analysis published in PLOS ONE indicated that Vitamin D deficiency was associated with an increased risk of severe COVID-19 and mortality.

Vitamin D Supplementation: What You Need to Know

Given the potential connection between Vitamin D deficiency and COVID-19, many people are considering Vitamin D supplementation. Here are some important points to keep in mind:

1. Consult a Healthcare Provider

Before starting any supplementation, it’s crucial to consult with a healthcare provider, especially to determine the appropriate dosage based on individual needs.

2. Dosage Recommendations

The recommended dietary allowance (RDA) for Vitamin D varies by age, gender, and life stage. Generally, 600-800 IU (International Units) per day is recommended for most adults. However, higher doses may be necessary for those with a Vitamin D deficiency.

3. Sources of Vitamin D

In addition to supplements, increasing dietary intake of Vitamin D-rich foods and ensuring adequate sun exposure can help maintain optimal levels.

4. Safety Considerations

While Vitamin D is generally safe, excessive intake can lead to toxicity, causing symptoms such as nausea, vomiting, weakness, and kidney damage.

The connection between Vitamin D deficiency and COVID-19 tells us that the importance of maintaining adequate Vitamin D is essential for our health and immune system. By ensuring enough Vitamin D intake through a combination of sunlight, diet, and supplements, health checkups individuals can support their immune system and improve their resilience against respiratory infections like COVID-19. One should avoid excessive dosage of Vitamin D because it may cause other health issues.

Also Read: The Different Types of Commodities

[trendingreportz]

DNA Vaccines Market - Forecast(2024 - 2030)

 DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2025, growing at a CAGR of 33.86% during the forecast period 2020-2025. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects. DNA based Vaccines concept deliver to cells after which the gene is expressed and can generate the protein of interest. Clinical trials of some DNA vaccines have shown promising results in the treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors. The demand for DNA Vaccines is experiencing rapid growth owing to factors such as adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals and others. With the rise of COVID-19 pandemic throughout the world 

Request Sample

Key Takeaways

North America dominates the DNA Vaccines Market owing to the increasing prevalence of infectious diseases in countries such as U.S and Canada.

Adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals are some of the key factors which are leading the demand for DNA Vaccines.

With the current COVID-19 Outbreak there is a huge demand for vaccination that can hack to build better immunity in order to fight the virus

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the DNA Vaccines Market.

By Type ��� Segment Analysis 

Based on the types, the DNA Vaccines Market is segmented into Human DNA Vaccines and Animal DNA Vaccines. Animal DNA vaccine is dominating the market in 2019 and is estimated to grow at a CAGR of 19.8% during the forecast period 2020-2025. This is owing to the unavailability of human DNA vaccines in the market along with the rising incidence of canine melanoma and other animal diseases. Animal vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response. Moreover, the strong pipeline of human targeted vaccines is likely to aid in the market growth

Inquiry Before Buying

By Application – Segment Analysis

Based on the applications, DNA Vaccines Market is segmented into Human Diseases which includes applications in Oncology, Infectious Disease, Allergies, and Veterinary Disease. The Veterinary Disease based on application is forecast to grow at a higher CAGR during the forecast period 2020-2025 owing to availability of DNA vaccines for animal diseases that includes canine melanoma vaccine (DOG), West Nile Innovator (Horse), Life tide-SW5 (Swine and other food animals) and Apex-IHN (Salmon fish). 

By Geography – Segment Analysis

Based on the geography the DNA Vaccines Market has covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). The Market in North America accounts for 43.7% of the total market share, which is attributed by government initiatives to immune citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. 

Asia Pacific region is set to be the highest growth during the forecast period 2020-2025 owing to rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B. Additionally, it is estimated that the DNA Vaccines Market is set to grow exponentially during the forecast period 2020-2025 owing to COVID-19 outbreak.

Schedule a Call

Market Drivers - DNA Vaccines Market

Rising Demand for effective treatment of infectious disease in driving market

DNA Vaccines used to kill and stop the growth of microorganisms. These drugs can act as a defense system for the human body and neutralize the action of disease causative agents. With increasing research activities and Increasing awareness and extensive R&D drugs, there is rising demand for treatment of infectious diseases

Challenges - DNA Vaccines Market

The main area of uncertainty is related to the immunological impact, tissue distribution and persistence after injection and whether the DNA vaccine can leak into the environment. This, in turn, create a challenging point for the growth of DNA Vaccine. Also, with, the limited efficiency of plasmid-based techniques precluded their use in the creation of more accurate human cell models is one of the challenges for DNA Vaccine Market

Buy Now

Vitamin & Mineral Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the DNA Vaccines Market. In 2019, DNA Vaccines Market share is consolidated by the top ten players present in the market. DNA Vaccines Market Top 10 companies include Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.

Acquisitions/Product Launches

In February 2020, Merck& Co announced the formation of a new, independent publicly-traded company focused on its Women’s Health, trusted Legacy Brands, and Biosimilars business. 

In February 2019, Merck & Co announced its acquisition of Immune Design Corp for nearly $300 million, gaining access to its immunotherapy programs.

[pranalip]

Ascorbic Acid Market Share, Trends, and Growth Reports | Global Insight Services

Global Insight Services has recently updated its global market reports, now including the latest data for 2024 and projections through 2033.

The global ascorbic acid market was valued at USD 1.3 billion in 2022 and it is anticipated to grow further till USD 2.3 billion by 2032, at a CAGR of 6.0% during the forecast period.

A water-soluble vitamin called ascorbic acid is beneficial for those with serious illnesses. The COVID-19 pandemic had a favorable effect on market growth because people needed more vitamin C to boost their immunity. Additionally, ascorbic acid was used to treat COVID-19 patients who had only minor symptoms. Additionally, people were more likely to take vitamin C supplements to maintain their health and strengthen their defenses against the infection.

To Know More@ https://www.globalinsightservices.com/reports/ascorbic-acid-market/?utm_id=Pranalip

Market Driver and Trends

In the following years, market growth is anticipated to be fueled by the increased demand for ascorbic acid in a number of industries, including baking, beverages, food processing, dietary supplements, and meat. Another important element boosting market expansion is the rise in cases of age-related macular degeneration and cataracts, as well as cancer, cardiovascular disease, the common cold, and cancer that can be protected by ascorbic acid absorption. In addition to the increased incidence of chronic diseases, the government’s expanding efforts to spread the word about ascorbic acid’s advantages will also present growth prospects for the ascorbic acid sector.

Request Sample@ https://www.globalinsightservices.com/request-sample/GIS24646/?utm_id=Pranalip

Research Objectives

Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region

Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

Identify factors influencing market growth and challenges, opportunities, drivers and restraints

Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market

To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Customization@ https://www.globalinsightservices.com/request-customization/GIS24646/?utm_id=Pranalip

Global Ascorbic Acid Market Segmentation

By Type

Potassium Ascorbate

Calcium Ascorbate

Magnesium Ascorbate

Others

By Application

Food & Beverages

Pharmaceutical

Beauty & Personal Care

Animal Feed

By Form

Powder

Liquid

 Major Players in the Global Ascorbic Acid Market

The key players studied in the report are BASF SE, Merck KGaA, Koninklijke DSM NV, Northeast Pharmaceutical Group Co. Ltd., Luwei Pharmaceutical Group Co. Ltd., Foodchem International Corporation, Honson Pharmatech Group, MC Biotec Inc., Freshine Chem, and CSPC Pharmaceutical Group among others.

COVID-19 Impact

The impact of COVID-19 has been detrimental to the overall economies of the affected countries, impeding economic growth, the smooth operation of the financial markets, the value of foreign currencies, and interest rates. The demand for ascorbic acid among food producers decreased as a result of changes in consumer tastes and perceptions, which hurt the manufacturers’ businesses by lowering sales and profitability.

Buy your copy here@ https://www.globalinsightservices.com/checkout/single_user/GIS24646/?utm_id=Pranalip

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing �� Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

lobal Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[healthcarehubhh]

Digestive Enzyme Market Supplements will grow at highest pace owing to increasing prevalence of lifestyle diseases

The digestive enzyme supplements market comprises supplements that contain enzymes like proteases, lipases, and amylases. These enzymes help in the breakdown of proteins, fats, and carbohydrates respectively during digestion. With hectic lifestyles and changing eating habits, digestive issues like indigestion, bloating, heartburn etc. have become quite common. Digestive enzyme supplements help boost digestive health and alleviate such symptoms. They are available as capsules, tablets, and powders and are taken before or after meals. The Global Digestive Enzyme Supplements Market is estimated to be valued at US$ 569 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the digestive enzyme supplements market are National Enzyme Company, Garden of Life LLC, Country Life LLC, Rainbow Light Nutritional System Inc., Food State Inc., Matsun Nutrition, Metagenics, Inc., TwinLab Corporation, Abbott Nutrition, Amway Corporation, Klaire Labs, Zenwise Health LLC, Integrative Therapeutics, LLC, Douglas Labs, Enzymedica Inc., Thorne Research Inc., Pure Encapsulations, LLC, Ortho Molecular Products Inc., Allergy Research Group, Biotics Research Corp. The growing prevalence of lifestyle diseases due to erratic schedules and unhealthy diets has fueled the demand for digestive enzyme supplements. Technological advancements have led to the development of more effective formulations with enhanced bioavailability and tolerability. Market Trends The digestive enzyme supplements market is witnessing increasing adoption of vegetarian and vegan formulations. With the rising trends of plant-based diets, manufacturers are developing supplements derived from non-animal sources like fungi and plants. Another key trend is the launch of digestive enzymes supplements targeted for specific symptoms and user groups. For example, supplements for gas, bloating, diarrhea or constipation and also formulations for children, adults or elderly. Market Opportunities Growth opportunities exist in emerging markets of Asia Pacific and Latin America owing to rising health consciousness. Market players can leverage the potential of online retailing and e-commerce platforms for marketing and sales of digestive enzyme supplements. Manufacturers can also focus on leveraging technologies like enteric coating for developing sustained-release supplements with enhanced efficacy. The COVID-19 pandemic has significantly impacted the growth of the digestive enzyme market. With rising cases of COVID-19 infections, most countries imposed nationwide lockdowns to curb the spread of the virus. This led to temporary closure of manufacturing facilities of various digestive enzyme products. Moreover, restrictions on logistic operations disrupted the supply chain, creating a significant shortage of enzymes in the market. However, post-lockdown easing, digestive enzyme manufacturers are focusing on expanding their production capacities and ensuring uninterrupted supply. They are also offering various online purchasing and delivery options to cater to growing demand. The pandemic has also increased awareness about maintaining optimum immunity and gut health. There is rising adoption of digestive enzymes as a supplementary diet to improve digestion as well as boost immunity against infections. Various clinical studies are being conducted to determine the efficacy of specific enzymes in the management of COVID-19 symptoms. Considering the long-term effects of COVID-19 on digestive system, the demand for enzymes is expected to remain high in the coming years. Manufacturers need to invest in R&D to develop novel formulations that can efficiently address digestive issues amidst the ongoing pandemic.

[covid-safer-hotties]

New COVID vaccines have arrived just as a vaccine equity program is ending - Published Aug 28, 2024

This article hits the nail on the the head: “We know the easier we make these vaccines, the more accessible these vaccines are, the more people will get them,” Jetelina said. “And they are expensive, especially for uninsured people; the whole access issue is a major challenge.”

Last week, the Food and Drug Administration approved two COVID-19 vaccines earlier than expected due to record-breaking surges of the virus. Instead of releasing them in the fall, following the pattern of previous coronavirus vaccine roll outs, they are available as early as this week. However, for some people, time is already running out to get the updated shots.

For the nearly 27 million adults who do not have health insurance, the new coronavirus vaccines will only be available for free until August 31. That’s because the Center for Disease Control and Prevention’s Bridge Access Program, which provided free coronavirus vaccines to uninsured adults, will end. Over the last year, the program provided free vaccines for nearly 1.5 million people since it launched in September 2023. Without insurance, the vaccine can cost at least $115.

“Uninsured adults are going to have more difficulty accessing the vaccines this fall,” Dr. Kelly Moore, president and CEO of Immunize.org, a nonprofit organization that works to increase vaccination rates and is funded by the CDC, told Salon. “Budget cuts on the federal government side have eliminated that program, and the amount of money available to purchase the COVID vaccine and offer it to people who are uninsured is quite limited.”

While the program was meant to be temporary, the original termination date for the program was slotted for December 2024. However, the fiscal 2024 government funding bill rescinded $4.3 billion in COVID-19 funding, some of which was being used for the program, as reported by The Hill in May. After August 31 of this year, local health departments might have a small amount of free vaccine available, but supply is expected to be limited for those without health insurance. While the Biden administration advocated for a more permanent solution in 2025, Congress hasn’t agreed to appropriate the funds.

“We hoped that the Bridge Access Program would be a bridge to a more permanent solution, a safety net program that would ensure affordable access to recommended vaccines for uninsured adults,” Moore said. “But unfortunately, it's turned out to be a bridge to nowhere.”

The ending of the program comes at a time when public health officials will be tasked with the assignment of getting vaccines into more peoples’ arms. The optics of last year’s vaccine roll-out was chaos, and not as many people received the vaccines as health officials hoped. Only about 28% of Americans received updated shots last year, a decline from 69% when the first round of vaccines were released.

In a statement to Salon, a spokesperson for the CDC said the Department of Health and Human Services (HHS) has started a campaign called "Risk Less. Do More." to increase uptake of vaccines, including for COVID. The public health agency said it is also "providing additional resources to support access to COVID vaccines this fall and winter season to serve needs of the most vulnerable populations, including uninsured adults, farmworkers, tribal populations and others."

"Much of that support will be provided to the 64 state and local public health departments through their immunization programs," the agency said.

This year, the two new vaccines are updated versions of the mRNA vaccines produced by Moderna and Pfizer-BioNTech, They are specifically designed to vaccinate people against the KP.2 strain, which has been driving a large proportion of infections this summer. For the last several weeks, related but different strains KP.3 and KP.3.1.1 have been the ones most responsible for infections lately. The vaccines still offer cross-protection against these variants, but it's another indicator that this virus will always be changing, evolving new ways of evading our immunity.

Want more health and science stories in your inbox? Subscribe to Salon's weekly newsletter Lab Notes.

“They have an updated vaccine formula, and that's a good thing,” Katelyn Jetelina, an epidemiologist and author of the newsletter Your Local Epidemiologist, told Salon. “This virus mutates incredibly quickly, and so we need to patch up our immunity walls to make sure we can recognize this vaccine or recognize the virus as it changes, and that is one driving factor why we have updated vaccines every fall.”

The vaccines are recommended for everyone six months and older, with a few exceptions. If you’ve had a recent COVID-19 infection, officials recommend waiting two to three months to get the vaccine. For everyone five years old and older, even if they’ve never been vaccinated against the coronavirus before, these two new vaccines only require one shot. Anyone younger than five may have multiple doses depending on whether they’ve been vaccinated before or not and what vaccine they received.

“The reason that we're no longer recommending multiple doses of vaccines for people who've never been vaccinated is that if you've never been vaccinated at this point, it's almost certain that you've had at least one infection with the coronavirus virus to prime your immune system,” Moore said. “So your immune system is already familiar with this virus, and it just needs to be reminded and updated with the latest vaccine.”

Moore said it’s most important for people who are older than 65, the age group where most serious COVID disease occurs, to receive the latest vaccine. According to the CDC’s data tracker, weekly deaths from COVID-19 have steadily risen across the country and wastewater viral activity has increased since May. Currently, the national level is “very high,” according to the CDC. One bit of good news is that the federal government plans to offer each household four free at-home COVID-19 tests again starting at the end of September.

Moore said aside from vaccine access being limited to uninsured Americans, she expects this year’s roll-out to be less chaotic than last year’s because people might have been experiencing “vaccine fatigue.”

“There was also a lot of distraction, in a positive way, about the offering of a new RSV vaccine available for the same sort of populations, older adults, 60 and over,” Moore said. “So there was a lot of focus on the RSV vaccine, and I think people just have been tired of thinking about COVID, and that's unfortunate because the vaccine is our best defense against COVID infection and the risk of long COVID.” *NADICA'S NOTE: Masking to not catch covid in the first place is the best defense against long covid*

Jetelina said it will be “interesting” to see if more people get vaccinated this year, especially since the HHS has a big vaccine campaign coming this fall that will target high-risk people.

“I'm curious if that will move the needle, but I will say I'm not holding my breath,” she said. “I don't think a lot of other things have changed since last year, people are still tired of hearing about COVID, there's still a lot of confusing information out there, and I don't know how many minds we can really, truly change from season to season.”

Jetelina said she is also concerned about the Bridge Access Program ending.

“We know the easier we make these vaccines, the more accessible these vaccines are, the more people will get them,” Jetelina said. “And they are expensive, especially for uninsured people; the whole access issue is a major challenge.”

[banarjeenikita]

Nutraceutical Manufacturing Companies: Market Trends and Consumer Preferences

The nutraceutical industry is booming, driven by an increasing consumer focus on health and wellness. Nutraceuticals, a term that combines “nutrition” and “pharmaceutical,” refer to food products that provide health and medical benefits, including the prevention and treatment of disease. As the industry grows, nutraceutical manufacturing companies are continually adapting to new market trends and shifting consumer preferences to stay competitive and meet the demands of health-conscious consumers.

The Growing Demand for Nutraceuticals

Several factors contribute to the rising demand for nutraceuticals. One of the primary drivers is the increasing awareness of the link between diet and health. Consumers are becoming more informed about the benefits of proactive health management and the role of nutrition in preventing chronic diseases. This trend is particularly evident in the aging population, which seeks to maintain health and vitality through natural means.

Additionally, the COVID-19 pandemic has heightened interest in immune-boosting supplements. Consumers are now more focused on strengthening their immune systems to safeguard against illnesses, leading to increased sales of vitamins, minerals, and herbal supplements.

Key Market Trends in Nutraceutical Manufacturing

Personalized Nutrition: One of the most significant trends in the nutraceutical industry is the move towards personalized nutrition. Consumers are looking for products tailored to their specific health needs, genetic profiles, and lifestyle choices. Nutraceutical manufacturers are responding by developing customized supplements and using advanced technologies like AI and genomics to create personalized health solutions.

Clean Label and Transparency: Modern consumers demand transparency about what they put into their bodies. Clean label products, which contain simple, recognizable ingredients without artificial additives, are becoming increasingly popular. Nutraceutical manufacturers are focusing on clean label formulations and providing detailed information about ingredient sourcing and product manufacturing processes.

Sustainability and Eco-Friendly Practices: Sustainability is a growing concern for consumers, influencing their purchasing decisions. Nutraceutical companies are adopting sustainable practices, such as using renewable energy sources, reducing waste, and sourcing raw materials responsibly. Eco-friendly packaging solutions, such as biodegradable and recyclable materials, are also gaining traction.

Plant-Based Products: The plant-based trend extends beyond food and into nutraceuticals. Plant-based supplements, including those derived from herbs, fruits, and vegetables, are becoming more popular. These products appeal to consumers seeking natural and organic options for their health needs.

Technological Advancements: Technological innovations are shaping the future of nutraceutical manufacturing. Advances in extraction technologies, such as supercritical CO2 extraction, allow for more efficient and cleaner production of nutraceuticals. Additionally, blockchain technology is being used to enhance transparency and traceability in the supply chain, providing consumers with verifiable information about product origins and quality.

Consumer Preferences in the Nutraceutical Industry

Understanding consumer preferences is crucial for nutraceutical manufacturers to develop products that resonate with their target audience. Here are some key consumer preferences driving the market:

Health and Wellness Focus: Consumers are prioritizing products that support overall health and wellness, including immune health, digestive health, and mental well-being. Nutraceuticals that offer multiple health benefits and are marketed as part of a holistic wellness approach are highly sought after.

Convenience and Accessibility: In today’s fast-paced world, consumers prefer nutraceuticals that are easy to integrate into their daily routines. Products such as ready-to-drink supplements, gummies, and single-serve sachets are popular due to their convenience and portability.

Trust and Credibility: Brand trust is a significant factor in consumer purchasing decisions. Companies that emphasize quality, efficacy, and safety, and that have third-party certifications, are more likely to gain consumer trust. Clear labeling, transparency, and credible endorsements further enhance brand credibility.

Aesthetic and Sensory Appeal: The sensory appeal of nutraceutical products, including taste, texture, and appearance, is increasingly important. Consumers are drawn to products that are not only effective but also enjoyable to consume. This preference drives innovation in product formulations and packaging.

Value for Money: While consumers are willing to invest in their health, they also seek value for money. Nutraceuticals that offer high-quality ingredients, proven benefits, and competitive pricing are more likely to succeed in the market.

Conclusion

The nutraceutical industry is evolving rapidly, driven by changing consumer preferences and emerging market trends. Nutraceutical manufacturing companies must stay agile and innovative to meet the growing demand for personalized, transparent, sustainable, and convenient health products. By understanding and responding to consumer needs, these companies can continue to thrive in an increasingly competitive landscape, contributing to the global movement towards proactive health and wellness.

[boostlete]

How Do Probiotics Work?

Fermented foods contain probiotic bacteria naturally. Their labels typically display the number of live organisms called colony forming units (CFUs). Supplements and other products designed to promote gut health may also include probiotics. They should help alleviate diarrhea, constipation and stomach discomfort. How do probiotics work? Your gut microbiome refers to the bacteria living within your digestive tract. These beneficial organisms aid digestion, nutrient absorption and your immune system - yet certain lifestyle choices like eating too much processed food and taking antibiotics may alter this balance - leading to digestive discomfort, irregular bowel movement and more frequent illness. Probiotics can help relieve or prevent digestive symptoms like diarrhea, bloating and IBS by increasing nutrient absorption and improving colon and ileum health. They may also aid in cases such as antibiotic-associated diarrhea, eczema and pregnancy nausea. Studies suggest that certain probiotics may protect against tooth decay by reducing plaque (a buildup of harmful bacteria on teeth). Furthermore, certain probiotics have also been shown to lower cancer risks by inhibiting tumor growth and decreasing angiogenesis activity. What are the health benefits of probiotics? Probiotic bacteria are essential in supporting digestion by helping absorb certain nutrients, boost your immune system and producing enzymes to aid with digestion. They are present in human bodies naturally in areas like mouth, skin, gut, intestines, vagina and urinary tract - you can find probiotics there too! You can access probiotics by eating fermented foods like yogurts with live cultures; kefir; aged cheeses; tempeh; miso; or taking dietary supplements available as capsules, liquids or powders. Studies of probiotics demonstrate their benefits by helping prevent infectious diarrhea, reduce antibiotic-associated diarrhea and alleviate other types of digestive upset including constipation, IBS, abdominal pain and bloating. They may even help combat chronic bacterial infections like H. pylori, nonalcoholic fatty liver disease and ulcerative colitis. Probiotics may provide additional protection from coronavirus infections by delaying symptoms associated with "cytokine storm," caused by COVID-19 (the pathogen previously known as SARS-CoV-2). Studies also suggest probiotics can moderately relieve symptoms associated with irritable bowel syndrome in certain people (65). What are the risks of taking probiotics? Probiotics have a longstanding record of safe use among healthy individuals. But additional high-quality research is necessary to understand how they may work for conditions like mental health, IBS and vaginal infections - and to be aware that effects vary between strains or brands. Probiotics may cause mild side effects in the initial days after starting to take them, particularly as your gut bacteria balance is resettled and restored. Most commonly these include stomach-related symptoms like gas and bloating. Probiotics have the potential to cause infections in those with compromised immune systems, including recent hospitalization or surgery patients. Furthermore, probiotics may alter how your brain works by altering production of mood-boosting and focus-increasing neurotransmitters--known as gut-brain connection. While research on probiotic consumption for older adults remains scarce, some studies indicate it can actually improve cognitive performance - it is advised to speak to your healthcare provider first before beginning probiotic supplementation. What are the best probiotics to take? Probiotics come in all shapes and sizes to improve gut health, so finding the one for you depends on what ailments you want to treat. Saccharomyces boulardii may relieve leaky gut (when molecules enter your bloodstream and cause inflammation and immune reactions), while Bifidobacterium lactis may reduce bloating and constipation. Your diet should include probiotic-rich foods and beverages like yogurt with live cultures or beverages like kefir, kombucha or sauerkraut. When choosing supplements that have been tested by third parties or are certified gluten-free and vegan. Probiotics have the ability to alter your gut microbiome and cause temporary side effects such as gas, bloating or diarrhea. But these should pass quickly once you start taking them; just follow the dosage instructions closely for multiple probiotics taken at once as this ensures their strain and amount of CFUs match what your doctor recommends. Read the full article

[chemicalsectorupdates]

Navigating Regulatory Frameworks in the Banana Puree Market

Banana Puree Market to grow at highest pace owing to Increasing Application in Baby Food and Dairy Products Banana puree is a thick and creamy paste made from peeled and mashed bananas. It is rich in potassium, fiber and vitamins like Vitamin C and Vitamin B6. Banana puree is extensively used in baby food formulas, smoothies, ice creams, beverages and other dairy products due to its nutritional benefits and flavoring properties. With over 200 varieties, bananas are among the most commonly consumed fruits in the world.

The Global Banana Puree Market is estimated to be valued at US$ 381.7 Mn in 2024 and is expected to exhibit a CAGR of 9.2% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the banana puree market are Symrise AG, Döhler GmbH, Kiril Mischeff, Riviana Foods Pty Ltd, Nestlé S.A., The Hain Celestial Group Inc, The Kraft Heinz Co., Ariza B.V., Newberry International Produce Limited, Grünewald Fruchtsaft GmbH. Growing demand for banana puree from baby food manufacturers is expected to drive the market during the forecast period. Technological advancements such as aseptic processing and concentration techniques are helping market players improve the shelf-life and consistency of banana puree. Market Trends Consumers are increasingly preferring organic and non-GMO banana purees owing to rising health consciousness. Many market players have launched organic and non-GMO certified banana puree products to cater to this demand. Secondly, with rising global banana production, banana puree export is growing rapidly from Latin American and Asian countries to North America and European markets. Market Opportunities Growing application of banana puree in dairy products such as yogurt and ice cream presents significant growth opportunities. Secondly, banana puree blends with other fruits is a new product trend gaining popularity among consumers and food manufacturers. Market players can capitalize on this opportunity by launching innovative blended fruit puree products. The COVID-19 pandemic had significant impacts on the banana puree market. Lockdowns and supply chain disruptions during 2020-2021 disrupted the production and distribution of banana puree. While demand increased as consumer cooked more at home, many suppliers faced issues in procuring raw materials and completing shipments. The restrictions on imports and exports adversely affected international trade of banana puree during this period. As lockdowns eased in 2021, the banana puree market saw a gradual recovery. Manufacturers focused on improving local sourcing and optimizing distribution networks to enhance resilience against future disruptions. Many companies invested in automated production and packaging facilities to ensure continuity of operations even during workforce shortages. The banana puree market is expected to benefit from rising health awareness in the post-COVID era. Consumers are increasingly preferring products with natural ingredients and perceived immunity-boosting properties. This augurs well for the future growth prospects of the banana puree market. In terms of value, Latin America accounts for the largest share in the global banana puree market mainly due to its dominant position in banana production and exports. Countries such as Ecuador, Philippines and Costa Rica are key suppliers globally. North America currently holds the second largest market share led by the United States. The banana puree market in Asia Pacific region is growing at fastest rate driven by rising consumption in populous countries like India and China. In Africa, countries importing raw bananas for processing are emerging as new lucrative markets for banana puree manufacturers and exporters. The Asia Pacific region presents significant growth opportunities for banana puree market participants and is expected to be the fastest growing geographical region through 2030. Rising health awareness, increasing affordability and significant imports of raw bananas in China and India for processing are driving banana puree demand momentum in Asia Pacific. Populous and increasingly urban regions like Southeast Asia and South Asia are witnessing higher consumption of convenience, organic and natural food products containing banana puree. This makes Asia Pacific an attractive prospect for banana puree manufacturers looking to expand market share internationally over the coming years.

[mamaketoblr]

Keto diet and Immunity

Keto diet is a high fat, moderate protein and a low carb diet. Following a well balanced keto diet switches your body to a fat metabolism state by limiting the availability of glucose in the system. In the ketogenic diet, meals usually consist of a variety of poultry, fish, meat, and non-starchy vegetables.

Lets see the impact of keto diet in improving immunity:

Keto diet protects us from influenza flu : The research from science immunology journal suggests that, following a keto diet provides protection against the lethal influenza infection.The ketogenic diet promotes the expansion of gamma delta T (γδ T) cells in the airways. These γδ T cells produce mucus in the linings of the lungs, which aids the body to get rid of infectious agents and also blocks the formation of inflammasomes, which can cause deleterious immune system responses

The ketogenic diet enhances immunity against malignant glioma: The research published in BMC cancer journal suggests that following a keto diet can increase the tumor-reactive innate and adaptive immune responses to help fight cancer causing agents.

Ketogenic diet positively affects immune cells: The study published in Nature Reviews Endocrinology suggests that ketogenic diet helps reduce inflammation and enhances metabolic outcomes.Following keto diet for 3–4 months shows the increased Gamma delta T calls which are metabolically protective against Autistic behaviour and overall metabolic functions of the body.

Decreases Fat Mass : Obesity has been identified as a risk factor for diabetic patienst and even COVID-19 hospitalization in patients under 60, This means that the COVID-19 infection tends to be more severe in obese individuals. When you consume more calories than you burn, your body stores those calories for a rainy day. This is a vital adaptive ability that has allowed the survival of humanity during times when food was scarce.Following a keto diet can help body use stored fat as its energy source for all the bodily function, hence reducing the accumulated fat and improving metabolism by boosting immunity to fight against pathogens and certain virus including covid- 19

Mama Keto’s motto is to provide nutritious meals, where lifestyle diseases can be addressed with well balanced Macro and Micro nutrients. Our personalised approach to each individual & bringing a variety of cuisines to meet all taste pallets ensures keto Diet is never boring.

Take Away:

The Ketogenic Diet appears to decrease inflammation as evidenced by improving inflammatory markers

This anti-inflammatory effect may boost the immune system by removing the burden of systemic chronic inflammation

The anti-inflammatory effects appear to be enhanced by choosing foods consistent with Keto diet.

The Ketogenic Diet is effective at reducing obesity which decreases inflammation and improves immunity and decreases risk and severity of infection

Keto diet and Immunity: Keto diet is a high fat, moderate protein and a low carb diet. Following a well balanced keto diet switches your body to a fat metabolism state by limiting the availability of glucose in the system. In the ketogenic diet, meals usually consist of a variety of poultry, fish, meat, and non-starchy vegetables.

Lets see the impact of keto diet in improving immunity:

Keto diet protects us from influenza flu: The research from science immunology journal suggests that, following a keto diet provides protection against the lethal influenza infection.The ketogenic diet promotes the expansion of gamma delta T (γδ T) cells in the airways. These γδ T cells produce mucus in the linings of the lungs, which aids the body to get rid of infectious agents and also blocks the formation of inflammasomes, which can cause deleterious immune system responses

The ketogenic diet enhances immunity against malignant glioma: The research published in BMC cancer journal suggests that following a keto diet can increase the tumor-reactive innate and adaptive immune responses to help fight cancer causing agents.

Ketogenic diet positively affects immune cells: The study published in Nature Reviews Endocrinology suggests that ketogenic diet helps reduce inflammation and enhances metabolic outcomes.Following keto diet for 3–4 months shows the increased Gamma delta T calls which are metabolically protective against Autistic behaviour and overall metabolic functions of the body.

Decreases Fat Mass : Obesity has been identified as a risk factor for diabetic patienst and even COVID-19 hospitalization in patients under 60, This means that the COVID-19 infection tends to be more severe in obese individuals. When you consume more calories than you burn, your body stores those calories for a rainy day. This is a vital adaptive ability that has allowed the survival of humanity during times when food was scarce.Following a keto diet can help body use stored fat as its energy source for all the bodily function, hence reducing the accumulated fat and improving metabolism by boosting immunity to fight against pathogens and certain virus including covid- 19

Take Away:

The Ketogenic Diet appears to decrease inflammation as evidenced by improving inflammatory markers

This anti-inflammatory effect may boost the immune system by removing the burden of systemic chronic inflammation

The anti-inflammatory effects appear to be enhanced by choosing foods consistent with Keto diet.

The Ketogenic Diet is effective at reducing obesity which decreases inflammation and improves immunity and decreases risk and severity of infection

Source Link

[molimor]

k

Groundnut oil, also known as Singtel or mungfali oil, has emerged as a nutritional powerhouse, offering a healthier alternative to edible oils. Derived from the original G20 groundnut and meticulously crafted by Molimor, groundnut oil stands out for its freshness and myriad health benefits. As the demand for nutritious yet delectable food options rises, let's delve into the ten benefits of incorporating groundnut oil into various recipes.

Groundnuts are undoubtedly protein-rich ingredients beneficial to health. However, achieving the finest quality requires a meticulous process, starting with sourcing from trustworthy farmers. Various attributes are available in the market, but the Molimor team prioritizes exceptional G20-quality groundnuts. Through extensive market research, the team identifies farmers cultivating this superior quality yield. The groundnuts are collected exclusively from these trusted farmers, ensuring a high-quality raw material. The subsequent oil manufacturing process is designed to maintain the integrity of all qualities and ingredients.

The Process of Making G20 Groundnut Oil:

Sorting and Grading: 

Directly from the farm, harvested groundnuts undergo a thorough cleaning process to remove dirt and impurities from the shells. The sorting phase involves carefully selecting the best-quality groundnuts, discarding rejected ones, and grouping similar types before moving on to the crushing stage.

2. Crushing or Oil Pressing: 

After the meticulous sorting process, the chosen groundnuts proceed to the oil-crushing phase. This step is time-consuming but crucial for extracting high-quality oil. Once the fat is removed, it is left to settle at room temperature for a duration of 48 hours before storage.

3. Filtration: 

Following the settling period, the oil undergoes meticulous filtration to eliminate any remaining residue or small particles. This filtration step is especially vital in cold press extraction, ensuring the resulting oil is pure and impurities-free. The fina

l filtration guarantees that the groundnut oil you receive is of the highest quality, clear, and devoid of unwanted materials.

4. Filling & Packaging: 

After meeting stringent inspection standards, the oil is transferred for filling and packaging. The process involves precise measurements to ensure accurate quantities, and the oil is carefully sealed in packaging that preserves its freshness and maintains quality throughout storage and transportation.

10 fantastic benefits of using groundnut oil?

 Heart-Friendly Properties: 

In light of the increasing occurrences of heart attacks among younger individuals, it is crucial to be mindful of heart health. Choosing natural, nutrient-rich foods without harmful additives is essential for maintaining cardiovascular well-being. Cold-pressed groundnut oil, abundant in heart-friendly monounsaturated fats, is pivotal in reducing unhealthy cholesterol levels. This, in turn, lowers the risk of heart disease and stroke. Incorporating groundnut oil into your cooking not only enhances flavour but also contributes to improved cardiovascular health.

2. Antioxidant Power: 

Post the COVID-19 pandemic, there's a heightened awareness of immunity and overall health. People are more conscious of their daily food choices, seeking nutritional sources to fortify their bodies against harmful influences. Enriched with vitamin E and resveratrol, groundnut oil is a potent antioxidant. These elements work synergistically to combat stress and inflammation in the body, promoting overall well-being. Including groundnut oil in your daily dietary routine becomes a valuable addition to support your body's defence mechanisms.

3. Rich in Vitamins: 

Groundnut oil is a natural source of various vitamins, elevating its nutritional profile. These vitamins contribute to overall health by supporting bodily functions and vitality. By incorporating groundnut oil into your meals, you enjoy delicious flavours and nourish your body with essential nutrients.

4. Good for Skin: 

Beyond its culinary use, groundnut oil provides essential nutrients for maintaining healthy skin. The vitamins and antioxidants present in the oil play a crucial role in promoting a radiant complexion. You contribute to internal and external well-being by including groundnut oil in your diet.

5. Easy Digestion:

The famous saying "har rog ka jad kab hai" emphasizes the role of constipation in various health issues. Constipation can hinder the efficient processing of consumed food, leading to serious health problems. Groundnut oil, being light and easily digestible, ensures that your digestive system functions smoothly. Choosing groundnut oil for your culinary needs promotes health and eases the digestive process, mitigating discomfort associated with heavier oils.

6. Immunity Booster: 

Regular consumption of groundnut oil can enhance the immune system. The natural compounds present in the oil work synergistically to strengthen the body's ability to fend off infections and illnesses. Making groundnut oil a staple in your kitchen becomes a proactive step toward bolstering overall health.

7. Ideal for Diabetic Individuals: 

Groundnut oil is a preferred choice for individuals managing diabetes due to its low glycemic index. This property assists in regulating blood sugar levels, making it a suitable option for those with diabetes. Including groundnut oil in your cooking allows you to enjoy flavorful meals while prioritizing your health.

8. Natural weight loss:  

While exercise is undeniably the best option for managing body weight, it's essential to recognize that dietary choices also significantly impact weight management. When integrated into a balanced diet, groundnut oil becomes a valuable contributor to natural weight loss. The healthy fats and nutrients in the oil support metabolic functions and offer sustained energy. This makes groundnut oil a beneficial addition for individuals striving to manage their weight effectively, complementing the benefits of regular exercise.

9. Mind Function Improvement: 

The nutritional content of groundnut oil, including omega-3 fatty acids, supports brain health and cognitive function. Regular consumption may improve focus, memory, and overall mental well-being.

10. Increased Energy: 

Groundnut oil is a source of healthy fats and energy, making it an excellent addition to your diet for an energy boost. The balanced composition of fats ensures sustained energy levels, making it suitable for individuals leading active lifestyles.

Conclusion: 

Incorporating groundnut oil into your daily cooking routine is not just a culinary choice but a health-conscious decision. With its myriad benefits, from promoting heart health to boosting immunity, groundnut oil is a valuable addition to your kitchen essentials. Molimor's commitment to quality and sourcing groundnuts from trusted farmers ensures that you experience the goodness of nature in every drop. Embrace the natural richness of groundnut oil for a healthier and tastier lifestyle.